.
.
.
AlArabiya
  • Language
    • English
    • عربي
    • فارسي
    • اردو
  • Home
  • News
    • Gulf
    • Middle East
    • North Africa
    • World
    • Saudi Arabia
    News
  • Business
    • Aviation and Transport
    • Economy
    • Markets
    • Bank and Finance
    • Retail
    • Technology
    Business
  • Energy
  • Opinion
  • Life
    • Art and Culture
    • Entertainment
    • Fashion and Beauty
    • Healthy Living
    • Travel and Tourism
    • Variety
    Life
  • Video
  • In Focus
Theme
  • Light
  • Dark
Language
  • English
  • عربي
  • فارسي
  • اردو
  • Home
    • Back
    • Russia Ukraine conflict
    • Terrorism
    • Iran Sanctions
    • Saudi Arabia
  • News
    • Back
    • Gulf
    • Middle East
    • North Africa
    • World
    • Saudi Arabia
  • Business
    • Back
    • Aviation and Transport
    • Economy
    • Markets
    • Bank and Finance
    • Retail
    • Technology
  • Energy
  • Opinion
  • Life
    • Back
    • Art and Culture
    • Entertainment
    • Fashion and Beauty
    • Healthy Living
    • Travel and Tourism
    • Variety
  • Video
  • In Focus
Results for

Pfizer

201 Results
  • Pfizer, BioNTech propose EU pays half for each canceled COVID dose: Report

    Pfizer, BioNTech propose EU pays half for each canceled COVID dose: Report

    Pfizer Inc and BioNTech’s new proposal to the European Union, amid a glut of COVID-19 shots, includes a provision for member states to pay half price, ...
    World News
  • Pfizer buys Seagen Inc. for $43 bln, boosts access to cancer drugs

    Pfizer buys Seagen Inc. for $43 bln, boosts access to cancer drugs

    Pfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue.The ...
    Healthy Living
  • US FDA approves nasal spray for migraines

    US FDA approves nasal spray for migraines

    The US Food and Drug Administration has approved a fast-acting nasal spray from Pfizer designed to treat migraines, the US pharmaceutical giant said ...
    Healthy Living
  • US FDA, CDC see early signal of Pfizer bivalent COVID-19 shot’s link to stroke

    US FDA, CDC see early signal of Pfizer bivalent COVID-19 shot’s link to stroke

    A safety monitoring system flagged that US drugmaker Pfizer Inc and German partner BioNTech’s updated COVID-19 shot could be linked to a type of brain ...
    Coronavirus
  • US pharma firms Merck, Pfizer rebuff China’s push for  price cuts on COVID-19 drugs

    US pharma firms Merck, Pfizer rebuff China’s push for price cuts on COVID-19 drugs

    Top US makers of COVID-19 drugs appear to be pushing back on China’s efforts to get them to cut their prices, underscoring the challenges the country ...
    Coronavirus
  • US FDA authorizes Moderna, Pfizer updated COVID-19 boosters for 6 months old children

    US FDA authorizes Moderna, Pfizer updated COVID-19 boosters for 6 months old children

    The US Food and Drug Administration on Thursday authorized updated COVID-19 booster shots from Moderna and Pfizer and its partner BioNTech for ...
    World News
  • Pfizer’s Paxlovid antiviral medication lowers long-COVID risk: Study

    Pfizer’s Paxlovid antiviral medication lowers long-COVID risk: Study

    Pfizer Inc.’s blockbuster Paxlovid antiviral that lowers rates of illness and death in people infected with the coronavirus also cuts the risk of some ...
    Coronavirus
  • US government to test Pfizer’s Paxlovid to treat long COVID 

    US government to test Pfizer’s Paxlovid to treat long COVID 

    The US National Institutes of Health’s $1 billion RECOVER Initiative has picked Pfizer Inc’s antiviral drug Paxlovid as the first treatment it will ...
    World News
  • Italy’s tax authorities investigate Pfizer profits: Sources

    Italy’s tax authorities investigate Pfizer profits: Sources

    Italy’s tax authorities are investigating profits reported by Pfizer Inc’s local unit Pfizer Italia srl, two sources with knowledge of the matter told ...
    World News
  • Pfizer COVID-19 vaccine clears Japan panel for use with young children

    Pfizer COVID-19 vaccine clears Japan panel for use with young children

    A Japanese health ministry panel on Wednesday recommended approving Pfizer Inc’s COVID-19 vaccine for children as young as six months old.Japan in ...
    Coronavirus
  • Booster jabs in GCC remain ‘critical’ to beat ‘unpredictable’ COVID-19: Pfizer chief

    Booster jabs in GCC remain ‘critical’ to beat ‘unpredictable’ COVID-19: Pfizer chief

    Residents in the GCC must continue to have regular booster jabs to combat the spread of the “highly unpredictable” and evolving COVID-19 virus, ...
    Coronavirus
  • EU drug regulator backs omicron-adapted COVID-19 booster shots

    EU drug regulator backs omicron-adapted COVID-19 booster shots

    The EU’s drug regulator on Thursday backed two separate COVID-19 vaccine boosters updated to target the omicron variant and developed by rivals ...
    Coronavirus
  • Moderna sues Pfizer/BioNTech for patent infringement over COVID-19 vaccine

    Moderna sues Pfizer/BioNTech for patent infringement over COVID-19 vaccine

    Moderna is suing Pfizer and its German partner BioNTech for patent infringement in the development of the first COVID-19 vaccine approved in the ...
    Coronavirus
  • EU regulator launches review of Pfizer-BioNTech's adapted COVID-19 vaccine

    EU regulator launches review of Pfizer-BioNTech's adapted COVID-19 vaccine

    The European Medicines Agency (EMA) has started a rolling review of a variant-adapted COVID-19 vaccine from Pfizer and BioNTech, it said on ...
    World News
  • Pfizer, BioNTech gain full FDA approval for COVID-19 vaccine for teens

    Pfizer, BioNTech gain full FDA approval for COVID-19 vaccine for teens

    Pfizer Inc. and BioNTech SE gained full US regulatory approval for their COVID-19 vaccine for teens 12 to 15 years old, a milestone that will allow ...
    Coronavirus
  • Omicron-specific COVID-19 vaccines could increase protection as boosters: EMA

    Omicron-specific COVID-19 vaccines could increase protection as boosters: EMA

    Coronavirus vaccines tweaked to include the omicron variant strain can improve protection when used as a booster, the European Medicines Agency and ...
    Coronavirus
  • BioNTech, Pfizer to start testing universal vaccine for COVID-19

    BioNTech, Pfizer to start testing universal vaccine for COVID-19

    Germany’s BioNTech, Pfizer’s partner in COVID-19 vaccines, said the two companies would start tests on humans of next-generation shots that protect ...
    Coronavirus
  • Pfizer says omicron-fighting COVID-19 shots prompt strong immune response 

    Pfizer says omicron-fighting COVID-19 shots prompt strong immune response 

    Pfizer Inc.’s omicron-targeting vaccine and a hybrid shot that fights the original strain as well as omicron prompted strong immune responses in a ...
    Coronavirus
  • US FDA opens way to COVID vaccines for children under five

    US FDA opens way to COVID vaccines for children under five

    The US Food and Drug Administration on Friday authorized two COVID-19 vaccines for children aged five and under, opening the door to vaccinating ...
    World News
  • Moderna COVID-19 vaccine may pose higher heart inflammation risk: US CDC

    Moderna COVID-19 vaccine may pose higher heart inflammation risk: US CDC

    Moderna’s COVID-19 vaccine may pose a higher risk of heart inflammation in some age groups than Pfizer-BioNTech’s shot, the US Centers for Disease ...
    Coronavirus
  • US: Pfizer COVID-19 shot appears effective for kids under five

    US: Pfizer COVID-19 shot appears effective for kids under five

    Federal health officials said Sunday that kid-sized doses of Pfizer’s COVID-19 vaccines appear to be safe and effective for kids under five, a key ...
    Coronavirus
  • Pfizer to sell all its patented drugs at non-profit price in 45 low-income countries

    Pfizer to sell all its patented drugs at non-profit price in 45 low-income countries

    Pfizer Inc will make all of its patented medicines including COVID-19 treatment Paxlovid and big-selling breast cancer drug Ibrance available at a not ...
    Healthy Living
  • WHO clears China’s CanSino COVID-19 vaccine for emergency use

    WHO clears China’s CanSino COVID-19 vaccine for emergency use

    The World Health Organization said Thursday that it has granted an emergency use authorization for the coronavirus vaccine made by China’s CanSino ...
    Coronavirus
  • Explainer: Some patients reporting COVID rebounds after taking Pfizer pills

    Explainer: Some patients reporting COVID rebounds after taking Pfizer pills

    More than 2.8 million courses of Pfizer Inc’s COVID-19 oral antiviral treatment Paxlovid have been made available at pharmacies around the United ...
    Coronavirus
  • Pfizer to spend $11.6B on migraine treatment maker Biohaven

    Pfizer to spend $11.6B on migraine treatment maker Biohaven

    Pfizer is spending more than $11.6 billion to buy the remaining portion of migraine treatment maker Biohaven Pharmaceuticals it does not already ...
    Financial Markets
  • J&J suspends sales forecast for COVID-19 vaccine, cuts profit view

    J&J suspends sales forecast for COVID-19 vaccine, cuts profit view

    Johnson & Johnson on Tuesday cut its full-year profit expectation and suspended sales forecast for its COVID-19 vaccine after having earlier predicted ...
    Coronavirus
  • Pfizer to expand COVID-19 booster shots to healthy five to 11-year-olds in US

    Pfizer to expand COVID-19 booster shots to healthy five to 11-year-olds in US

    Pfizer said Thursday it wants to expand its COVID-19 booster shots to healthy elementary-age kids.US health authorities already urge everyone 12 and ...
    Coronavirus
  • Pfizer to buy lung-focused biotech developer ReViral for as much as $525 mln

    Pfizer to buy lung-focused biotech developer ReViral for as much as $525 mln

    Pfizer Inc. agreed to buy respiratory antiviral developer ReViral Ltd. for as much as $525 million, the COVID-19 vaccine maker’s latest move in the ...
    Business
  • Current COVID-19 vaccines not ‘well-matched’ against BA.2: FDA

    Current COVID-19 vaccines not ‘well-matched’ against BA.2: FDA

    Current COVID-19 vaccines are not well-matched against the BA.2 sub-variant of omicron, the US Food and Drug Administration said on Wednesday, as its ...
    Coronavirus
  • China approves Pfizer’s COVID pill Paxlovid for mild to moderate cases

    China approves Pfizer’s COVID pill Paxlovid for mild to moderate cases

    China’s medical products regulator said on Saturday it has given conditional approval for Pfizer’s COVID-19 drug Paxlovid, making it the first oral ...
    World News
You’ve viewed 30 of 201 results
  • 1
  • 2
  • 3
  • 4
  • 5
  • ...
  • 7
Home tools Tag Results

  • News
    • Middle East
    • North Africa
    • Gulf
    • Saudi Arabia
    • World
  • Business
    • Economy
    • Technology
    • Markets
  • Energy
  • Opinion
  • Life
  • Video
Subscribe to our Newsletter

  • About Al Arabiya Network
  • Contact us
  • Terms of use
  • Privacy policy
  • Careers
  • Speak Up
© Copyright. Al Arabiya Network. 2023
Language
  • English
  • عربي
  • فارسي
  • اردو

This website uses "cookies":

We use cookies to improve your experience on our site and to show you personalized advertising. To continue browsing, please click ‘OK, I Accept’.

For more information, please read our Privacy Policy

Ok, I Accept